ADVANCED LUNG ADENOCARCINOMA
Clinical trials for ADVANCED LUNG ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED LUNG ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED LUNG ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo targets hard-to-treat lung cancer
Disease control Recruiting nowThis study tests a combination of two experimental drugs, bemcentinib and pacritinib, in people with advanced lung adenocarcinoma that has not responded to standard treatments. The goal is to see if the combination can shrink tumors or slow cancer growth. About 44 participants wi…
Matched conditions: ADVANCED LUNG ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated May 01, 2026 15:56 UTC
-
New hope for hard-to-treat lung cancer: triple therapy targets resistant tumors
Disease control Recruiting nowThis study tests a combination of two targeted drugs (defactinib and avutometinib) plus an immunotherapy (nivolumab) in 50 adults with advanced LKB1-mutant lung adenocarcinoma that no longer responds to standard anti-PD1 treatment. The goal is to see if this triple therapy can sh…
Matched conditions: ADVANCED LUNG ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC